Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb Statistics
Share Statistics
Bristol-Myers Squibb has 2.03B shares outstanding. The number of shares has increased by 0.3% in one year.
| Shares Outstanding | 2.03B |
| Shares Change (YoY) | 0.3% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 74.35% |
| Shares Floating | 2.03B |
| Failed to Deliver (FTD) Shares | 150 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 27.52M, so 1.36% of the outstanding shares have been sold short.
| Short Interest | 27.52M |
| Short % of Shares Out | 1.36% |
| Short % of Float | 1.36% |
| Short Ratio (days to cover) | 2.42 |
Valuation Ratios
The PE ratio is -12.81 and the forward PE ratio is 8.46. Bristol-Myers Squibb's PEG ratio is 0.06.
| PE Ratio | -12.81 |
| Forward PE | 8.46 |
| PS Ratio | 2.37 |
| Forward PS | 3 |
| PB Ratio | 7.02 |
| P/FCF Ratio | 8.22 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bristol-Myers Squibb.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 3.13.
| Current Ratio | 1.25 |
| Quick Ratio | 1.15 |
| Debt / Equity | 3.13 |
| Total Debt / Capitalization | 75.81 |
| Cash Flow / Debt | 0.3 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.55% and return on capital (ROIC) is 0%.
| Return on Equity (ROE) | -0.55% |
| Return on Assets (ROA) | -0.1% |
| Return on Capital (ROIC) | 0% |
| Revenue Per Employee | 1.42M |
| Profits Per Employee | -262.40K |
| Employee Count | 34.10K |
| Asset Turnover | 0.52 |
| Inventory Turnover | 4.67 |
Taxes
| Income Tax | 554.00M |
| Effective Tax Rate | -0.07 |
Stock Price Statistics
The stock price has increased by 9.61% in the last 52 weeks. The beta is 0.45, so Bristol-Myers Squibb's price volatility has been higher than the market average.
| Beta | 0.45 |
| 52-Week Price Change | 9.61% |
| 50-Day Moving Average | 57.21 |
| 200-Day Moving Average | 50.52 |
| Relative Strength Index (RSI) | 40.34 |
| Average Volume (20 Days) | 12.14M |
Income Statement
In the last 12 months, Bristol-Myers Squibb had revenue of 48.30B and earned -8.95B in profits. Earnings per share was -4.41.
| Revenue | 48.30B |
| Gross Profit | 36.35B |
| Operating Income | 0 |
| Net Income | -8.95B |
| EBITDA | 3.17B |
| EBIT | n/a |
| Earnings Per Share (EPS) | -4.41 |
Balance Sheet
The company has 10.35B in cash and 51.20B in debt, giving a net cash position of -40.85B.
| Cash & Cash Equivalents | 10.35B |
| Total Debt | 51.20B |
| Net Cash | -40.85B |
| Retained Earnings | 14.91B |
| Total Assets | 92.60B |
| Working Capital | 6.01B |
Cash Flow
In the last 12 months, operating cash flow was 15.19B and capital expenditures -1.25B, giving a free cash flow of 13.94B.
| Operating Cash Flow | 15.19B |
| Capital Expenditures | -1.25B |
| Free Cash Flow | 13.94B |
| FCF Per Share | 6.88 |
Margins
Gross margin is 75.26%, with operating and profit margins of 0% and -18.53%.
| Gross Margin | 75.26% |
| Operating Margin | n/a |
| Pretax Margin | -17.35% |
| Profit Margin | -18.53% |
| EBITDA Margin | 6.56% |
| EBIT Margin | n/a |
| FCF Margin | 28.87% |
Dividends & Yields
BMY pays an annual dividend of $2.48, which amounts to a dividend yield of 4.51%.
| Dividend Per Share | $2.48 |
| Dividend Yield | 4.51% |
| Dividend Growth (YoY) | 8.77% |
| Payout Ratio | -56.24% |
| Earnings Yield | -7.9% |
| FCF Yield | 12.31% |
Analyst Forecast
The average price target for BMY is $61, which is 9.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $61 |
| Price Target Difference | 9.3% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Aug 7, 2001. It was a forward split with a ratio of 1000000:951777.
| Last Split Date | Aug 7, 2001 |
| Split Type | forward |
| Split Ratio | 1000000:951777 |
Scores
| Altman Z-Score | 1.46 |
| Piotroski F-Score | 3 |